Premium
Utilization of palliative care consultations in pediatric oncology phase I clinical trials
Author(s) -
Cuviello Andrea,
Boss Renee,
Shah Nirali,
Battles Haven,
Beri Andrea,
Wiener Lori
Publication year - 2019
Publication title -
pediatric blood and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.116
H-Index - 105
eISSN - 1545-5017
pISSN - 1545-5009
DOI - 10.1002/pbc.27771
Subject(s) - medicine , palliative care , intensive care medicine , clinical trial , pediatric oncology , quality of life (healthcare) , refractory (planetary science) , disease , retrospective cohort study , medline , cancer , nursing , physics , astrobiology , political science , law
Pediatric phase I clinical oncology trials represent a unique cohort of patients who have not responded to standard therapies and remain highly vulnerable to treatment toxicity and/or disease burden. Incorporating a palliative care consultation into the care plan for those with relapsed/refractory cancer where chance of cure is limited is generally recommended. A retrospective chart review of pediatric phase I trials revealed that palliative care was consulted in <20% of patients, most often for symptom management. Efforts to increase the use of palliative services in this population may enhance quality of life for children and families enrolled in phase I studies.